Welcome to LookChem.com Sign In|Join Free
  • or
2-[3-(HYDROXYMETHYL)PHENYL]ACETIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

149492-32-0

Post Buying Request

149492-32-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

149492-32-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 149492-32-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,4,9 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 149492-32:
(8*1)+(7*4)+(6*9)+(5*4)+(4*9)+(3*2)+(2*3)+(1*2)=160
160 % 10 = 0
So 149492-32-0 is a valid CAS Registry Number.

149492-32-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-hydroxymethylphenylacetic acid

1.2 Other means of identification

Product number -
Other names (3-hydroxymethyl-phenyl)-acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:149492-32-0 SDS

149492-32-0Relevant academic research and scientific papers

BICYCLOR [2.2.1] HEPT-7-YLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES AND CONDITIONS IN WHICH M3 MUSCARINIC RECEPTOR ACTIVITY AND BETA-ADRENERGIC ACTIVITY ARE IMPLICATED

-

, (2009/01/24)

The present invention relates to compounds of formula (I) having muscarinic M3 receptor and β-adrenergic receptor modulating activity; wherein R1, R2, R3 and X are as defined herein.

NEW CHEMICAL COMPOUNDS

-

Page/Page column 79, (2008/12/08)

The present invention provides compounds of formula (I) having muscarinic M3 receptor and β-adrenergic receptor modulating activity; processes for their preparation and their use in therapy; wherein A, R1, R2, R3 and Rsup

TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

-

Page 78, (2010/02/10)

The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.

SYNTHESIS OF A NOVEL MACROCYCLIC LACTONE SYSTEM

Smith, Keith,Morris, Ian K.,Bass, Robert J.

, p. 1865 - 1872 (2007/10/02)

A total synthesis of a 14-membered ring lactone (3) with potential biological activity is described.The final lactonization step uses a modification of the Corey pyridinethiol ester procedure.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 149492-32-0